日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

GPS1 Exon 9 Mutations Represent a Rare Genetic Event in Penile Squamous Cell Carcinoma Pathogenesis

GPS1基因第9外显子突变是阴茎鳞状细胞癌发病机制中一种罕见的遗传事件。

Tögel, Lars; Elsner, Felix; Wendler, Olaf; Giedl, Johannes; Gaisa, Nadine T; Richter, Georg; Campean, Valentina; Burger, Maximilian; Wullich, Bernd; Bertz, Simone; Hartmann, Arndt; Stoehr, Robert

A phase 1, multicenter, open-label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraine

一项 1 期、多中心、开放标签研究,旨在评估单剂量瑞美吉泮在有偏头痛病史的儿童(年龄 ≥6 岁至 <12 岁)中的药代动力学、安全性和耐受性。

Lim, Chay Ngee; Mo, Gary; Bhardwaj, Rajinder; Comisar, Craig M; Emerson, Beth L; Matschke, Kyle T; Fisniku, Ogert; Bertz, Richard; Croop, Robert; Liu, Jing

Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors

在低甲基化药物和BCL2抑制剂时代,供体淋巴细胞输注治疗异基因造血干细胞移植后髓系肿瘤复发

Jovein, Miriam Mozaffari; Meyer, Thomas; Waterhouse, Miguel; Pfeifer, Dietmar; Duque-Afonso, Jesús; Lübbert, Michael; Maas-Bauer, Kristina; Wäsch, Ralph; Bertz, Hartmut; Duyster, Justus; Zeiser, Robert; Finke, Jürgen; Wehr, Claudia

A Phase 1, Randomized, Placebo-Controlled, Multiple-Dose, Double-Blind Study to Evaluate and Compare the Pharmacokinetics and Safety of Rimegepant in Healthy Adult Japanese and Caucasian Individuals

一项 1 期随机、安慰剂对照、多剂量、双盲研究,旨在评估和比较瑞美吉泮在健康日本成年人和白种人中的药代动力学和安全性。

Bhardwaj, Rajinder; Lim, Chay Ngee; Li, Yinhua; Matschke, Kyle T; Bertz, Richard; Croop, Robert; Liu, Jing

Between- and within-person predictors of missingness in intensive longitudinal data among people in outpatient treatment for opioid use disorder

门诊接受阿片类药物使用障碍治疗患者的密集纵向数据中缺失值的个体间和个体内预测因素

Stull, Samuel W; Mogle, Jacqueline; Panlilio, Leigh V; Wolchok, Rachel; Lanza, Stephanie T; Bertz, Jeremiah W; Epstein, David H

Machine learning-based prediction of one-year mortality after alloHCT identifies the impact of pre-transplant immunity and inflammation

基于机器学习的异基因造血干细胞移植后一年死亡率预测揭示了移植前免疫和炎症的影响

Meyer, Thomas; Meyer, Robert; Hackenberg, Maren; Oelke, Daniela; Gengenbach, Laura; Rummelt, Christoph; Wilcken, Hauke; Maas-Bauer, Kristina; Wäsch, Ralph; Duyster, Justus; Bertz, Hartmut; Duque-Afonso, Jesús; Finke, Jürgen; Zeiser, Robert; Wehr, Claudia

Effects of multiple-dose administration of zavegepant nasal spray on the single-dose pharmacokinetics of ethinyl estradiol-levonorgestrel

多次使用扎维吉泮鼻喷雾剂对单剂量炔雌醇-左炔诺孕酮药代动力学的影响

Bhardwaj, Rajinder; Collins, Julie; Madonia, Jennifer; Matschke, Kyle; Bertz, Richard; Liu, Jing

Characterization of rimegepant drug-drug interactions using the cytochrome P450 probe drugs, itraconazole, rifampin, fluconazole, and midazolam

利用细胞色素P450探针药物伊曲康唑、利福平、氟康唑和咪达唑仑对瑞美吉泮的药物相互作用进行表征

Bhardwaj, Rajinder; Morris, Beth; Matschke, Kyle T; Bertz, Richard; Croop, Robert; Liu, Jing

Assessment of pharmacokinetic and pharmacodynamic interactions between zavegepant and sumatriptan: A phase 1, randomized, placebo-controlled study in healthy adults

评估扎维吉泮和舒马曲坦之间的药代动力学和药效学相互作用:一项在健康成人中进行的 I 期随机、安慰剂对照研究

Bhardwaj, Rajinder; Donohue, Mary K; Madonia, Jennifer; Matschke, Kyle; Anderson, Matt S; Morris, Beth; Bertz, Richard; Croop, Robert; Liu, Jing

Comparative bioavailability of single-dose zavegepant during and between migraine attacks: A phase 1, randomized, open-label, fixed-sequence, two-period study

单剂量扎维吉泮在偏头痛发作期间和发作间期的生物利用度比较:一项 1 期随机、开放标签、固定顺序、两周期研究

Bertz, Richard J; Collins, Julie L; Madonia, Jennifer; Bhardwaj, Rajinder; Kamen, Lisa; Matschke, Kyle T; Liu, Jing